Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

USCOM LIMITED Board/Management Information 2011

Aug 30, 2011

65979_rns_2011-08-30_4ef52dcd-ee8e-4dba-81c0-a92a7b235b82.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

Uscom Limited ABN 35 091 028 090 Suite 1, Level 7, 10 Loftus Street Sydney NSW 2000 Australia T +612 9247 4144 F +612 9247 8157 www.uscom.com.au

M A R K E T A N N O U N C E M E N T

Director resignation

Wednesday 31st of August 2011: Uscom (ASX code: UCM).

Uscom announces today that it has received the resignation of Mr. Bruce Rathie as a director of the company effective immediately.

Mr. Rathie sited increasing commitments elsewhere for his departure.

The board thanks Mr. Rathie for his contributions to the company over the past 4 years and wishes him well in his future endeavors.

About Uscom

Uscom Limited is an Australian medical device company which was first listed on the Australian Stock Exchange in December 2003. Uscom has developed a Non Invasive Cardiac Output Monitor. The USCOM is a simple, cost-effective and non-invasive device that measures heart function, detects irregularities and guides treatment. The USCOM device has major applications in Paediatrics, Emergency Medicine, Intensive Care Units and Anesthesia, and is a tool of choice for management of adult and paediatric sepsis, and for the guidance of all fluid administration. USCOM has global regulatory approval and the technology is currently marketed in North America, South America, Europe, the Middle East, India, Australia & New Zealand. China and SE Asia.

Uscom Contacts Phil Kiely Executive Chairman [email protected]

Daniel Fah Company Secretary [email protected]